Savara Inc_
Stock Overview
About
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in 2007 and is headquartered in Langhorne, Pennsylvania.
Company Details
Frequently Asked Questions
What does Savara Inc do?
Savara Inc is a company in the Biotechnology industry. Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulatin
Where is Savara Inc headquartered?
Savara Inc is headquartered in Langhorne, PA, United States.
How many employees does Savara Inc have?
Savara Inc employs approximately 59 people worldwide.
Is Savara Inc publicly traded?
Yes, Savara Inc is a publicly traded company with the stock ticker symbol SVRA.
